Cargando…

Role of (18)FDG PET/CT metabolic parameters in predicting hematological toxicity during chemoradiotherapy for locally advanced cervical cancer

PURPOSE: The aim of this study is to evaluate the value of (18)FDG PET/CT metabolic parameters in predicting hematological toxicity (HT) during chemoradiotherapy (CRT) for locally advanced cervical cancer (LACC). METHODS AND MATERIALS: Forty-one patients with LACC undergoing concurrent CRT were retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Tianyu, Meng, Xiangxi, Xu, Xiaoxia, Li, Xiaofan, Yang, Zhi, Li, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433863/ https://www.ncbi.nlm.nih.gov/pubmed/36059649 http://dx.doi.org/10.3389/fonc.2022.956652

Ejemplares similares

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

The Role of the Metabolic Parameters of (18)F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
por: Wang, Dunhuang, et al.
Publicado: (2021)

Cervical cancer evaluated with integrated (18)F-FDG PET/MR
por: Gong, Jing, et al.
Publicado: (2019)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer
por: Burchardt, Ewa, et al.
Publicado: (2023)

The diagnostic value of [(18)F]-FDG-PET/CT in hematopoietic radiation toxicity: a Tibet minipig model
por: Chen, Chi, et al.
Publicado: (2012)

Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy
por: Scarsbrook, Andrew, et al.
Publicado: (2016)

Everolimus-induced pulmonary toxicity: Findings on (18)F-FDG PET/CT imaging
por: Dejust, Sebastien, et al.
Publicado: (2018)

Quantitative parameters of static imaging and fast kinetics imaging in (18)F-FDG total-body PET/CT for the assessment of histological feature of pulmonary lesions
por: Meng, Nan, et al.
Publicado: (2023)

Diagnostic Accuracy of (18)F-FDG-PET/CT and (18)F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI
por: Murtojärvi, Sarita, et al.
Publicado: (2022)

Threshold of Clinical Severity of Cervical Dystonia for Positive (18)F-FDG PET/CT
por: Lee, Hyun Jung, et al.
Publicado: (2013)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

Retrospective Analysis of the Predictive Value of (18)F-FDG PET/CT Metabolic Parameters for PD-L1 Expression in Cervical Cancer
por: Ji, Jianfeng, et al.
Publicado: (2023)

[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy
por: Herrera, Fernanda G., et al.
Publicado: (2016)

Predicting the Efficacy of SBRT for Lung Cancer with (18)F-FDG PET/CT Radiogenomics
por: Chen, Kuifei, et al.
Publicado: (2023)

Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis
por: Sanei Sistani, Sharareh, et al.
Publicado: (2021)

Textural features of cervical cancers on FDG-PET/CT associate with survival and local relapse in patients treated with definitive chemoradiotherapy
por: Chen, Shang-Wen, et al.
Publicado: (2018)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

(18)F-FDG PET/CT metabolic parameters correlate with EIF2S2 expression status in colorectal cancer
por: Yang, Jian-Wei, et al.
Publicado: (2021)

[(18)F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[(18)F]FDG PET/CT
por: Mu, Xingyu, et al.
Publicado: (2022)

(18)F-FDG PET–CT Diagnosis of Tuberculosis in Celiac Lymph Nodes
por: Mao, Xi Bao, et al.
Publicado: (2020)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Prognostic role of pretreatment (18)F-FDG PET/CT and hematological parameters in relapsed/refractory Hodgkin lymphoma patients treated with immune checkpoint inhibitors and chemotherapy: a dual-center cohort study
por: Yang, Tianyu, et al.
Publicado: (2023)

What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
por: Kunikowska, Jolanta, et al.
Publicado: (2014)

Clinical correlation of metabolic parameters on (18)F-FDG PET/CT in idiopathic frozen shoulder
por: Won, Kyoung Sook, et al.
Publicado: (2017)

Prognostic Significance of Metabolic Parameters by (18)F-FDG PET/CT in Thymic Epithelial Tumors
por: Lee, Joohee, et al.
Publicado: (2021)

The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma
por: Prestwich, Robin J. D., et al.
Publicado: (2012)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Metabolic patterns on [(18)F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Use of Baseline (18)F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
por: Lucia, François, et al.
Publicado: (2020)

Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy
por: Lucia, François, et al.
Publicado: (2020)

The Prognostic Value of Sequential (18) F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy
por: Ha, Le Ngoc, et al.
Publicado: (2023)

Characteristics of thyroid incidentalomas detected by pre-treatment [(18)F]FDG PET or PET/CT in patients with cervical cancer
por: Lee, Won-Moo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7n2i8q2gms1rb6o1kjuu5eierh